Millennium Management LLC lowered its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 79.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,805 shares of the company’s stock after selling 22,468 shares during the period. Millennium Management LLC’s holdings in U.S. Physical Therapy were worth $419,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in USPH. Copeland Capital Management LLC acquired a new stake in U.S. Physical Therapy during the fourth quarter worth approximately $12,459,000. BlackRock Inc. grew its stake in U.S. Physical Therapy by 2.5% in the fourth quarter. BlackRock Inc. now owns 1,621,087 shares of the company’s stock valued at $117,043,000 after acquiring an additional 40,093 shares during the period. Wells Fargo & Company MN grew its stake in U.S. Physical Therapy by 24.6% in the fourth quarter. Wells Fargo & Company MN now owns 91,620 shares of the company’s stock valued at $6,615,000 after acquiring an additional 18,078 shares during the period. Algert Global LLC grew its stake in U.S. Physical Therapy by 89.4% in the fourth quarter. Algert Global LLC now owns 33,565 shares of the company’s stock valued at $2,423,000 after acquiring an additional 15,845 shares during the period. Finally, King Luther Capital Management Corp grew its stake in U.S. Physical Therapy by 26.7% in the fourth quarter. King Luther Capital Management Corp now owns 73,120 shares of the company’s stock valued at $5,279,000 after acquiring an additional 15,425 shares during the period. 95.26% of the stock is owned by institutional investors and hedge funds.

A number of equities research analysts have commented on USPH shares. Jefferies Group set a $76.00 price objective on U.S. Physical Therapy and gave the company a “hold” rating in a research note on Friday, February 23rd. Cantor Fitzgerald raised their price objective on U.S. Physical Therapy to $90.00 and gave the company an “overweight” rating in a research note on Friday, March 9th. ValuEngine raised U.S. Physical Therapy from a “hold” rating to a “buy” rating in a research note on Monday, April 2nd. Zacks Investment Research raised U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $89.00 price objective for the company in a research note on Wednesday, March 7th. Finally, Barrington Research reissued a “hold” rating on shares of U.S. Physical Therapy in a research note on Friday, March 9th. Six research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $79.40.

Shares of U.S. Physical Therapy opened at $92.65 on Friday, MarketBeat reports. The company has a market cap of $1.14 billion, a P/E ratio of 44.54, a P/E/G ratio of 3.27 and a beta of 1.09. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.67 and a current ratio of 1.67. U.S. Physical Therapy, Inc. has a 12-month low of $90.70 and a 12-month high of $91.05.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Thursday, May 3rd. The company reported $0.56 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.56. The company had revenue of $108.34 million for the quarter, compared to analysts’ expectations of $107.18 million. U.S. Physical Therapy had a return on equity of 13.20% and a net margin of 4.90%. research analysts predict that U.S. Physical Therapy, Inc. will post 2.45 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, June 8th. Investors of record on Friday, May 11th will be given a dividend of $0.23 per share. The ex-dividend date of this dividend is Thursday, May 10th. This represents a $0.92 annualized dividend and a dividend yield of 0.99%. U.S. Physical Therapy’s payout ratio is 44.23%.

In related news, Director Bernard A. Harris, Jr. sold 6,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, March 12th. The stock was sold at an average price of $86.53, for a total transaction of $519,180.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO Glenn Mcdowell sold 2,900 shares of U.S. Physical Therapy stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $82.55, for a total value of $239,395.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 38,204 shares of company stock worth $3,383,648. 2.50% of the stock is owned by insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.